FloridaBill SenateText - 2023ACR-145 (NP)Triple-Negative SR 138 By Senator Berman 26-00351-23 2023138__ Senate Resolution A resolution recognizing March 2023 as “Triple- Negative Breast Cancer Awareness Month”Day and MarchMonth. 3, 2023, as “Triple-Negative Breast Cancer Awareness Day” in Florida.

7skip WHEREAS, breast cancer is among the most commonly diagnosed cancers and is the second leading cause of cancer death among women in the United States, and WHEREAS, some 287,850 women were diagnosed with breast cancer in 2022 and more than 43,000 were expected to diecontent fromhome thisaccessibility malignancy,FAQ andfeedback WHEREAS,sitemap triple-negativelogin breastx cancerQuick (TNBC)Search: is one of many forms of breast cancer and accounts for between 15 and 30 percent of all diagnosed invasive breast cancer cases nationwide, and WHEREAS, of the new breast cancer cases diagnosed in the United States in 2019, more than 53,700 were TNBC, with higher prevalence among younger women;

blackBill andNumber HispanicBill women;Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill Text PDF2 Bill PDF |Add To My Favorites | Version:

women03/28/22 with- typeChaptered 203/22/22 diabetes- orEnrolled carrying02/17/22 excess- weightIntroduced inACR-145 theTriple-Negative abdominalBreast area;Cancer Awareness Day and Month.(2021-2022) Text >> Votes >> History >> Bill Analysis >> Today's Law As Amended >> Compare Versions >> Status >> Comments To Author >> Add To My Favorites >> SHARE THIS:

andACR145:v97#DOCUMENTBill thoseStart womenAssembly withConcurrent BRCA1Resolution mutations,No. and WHEREAS, due to its aggressive behavior, TNBC grows quickly and is more likely to have spread by the time it is found and to recur after treatment than other types of breast cancer, and WHEREAS, people diagnosed with metastatic TNBC have less than a 30 percent chance of surviving 5 years after diagnosis, and WHEREAS, TNBC cells do not contain and are considered negative for the three key receptors that medicines typically Page 1 of 3 CODING:

Words145 strickenCHAPTER are28 deletions;Relative to triple-negative breast cancer.

words[ underlinedFiled arewith additions.Secretary of State  March 28, 2022.

Florida] SenateLEGISLATIVE -COUNSEL'S 2023DIGESTACR (NP)145, SRReyes. 138 26-00351-23 2023138__ target in other types of breast cancers and, therefore, limited treatment options are available to treat this cancer, and WHEREAS, while patients with an early diagnosis can often be treated with chemotherapy, radiation, and surgery, the limited availability of therapies that specifically address the management of TNBC has made treating this disease a challenge for clinicians, and WHEREAS, recent innovations in targeted therapies have fueled advances in the fight against TNBC, and WHEREAS, studies have shown that TNBC-disease-specific mortality rates are often higher if patients are enrolled in Medicaid or Medicare or have a lower socioeconomic status and that black women are 48 percent less likely than non-Hispanic white women to receive guideline-adherent care and have approximately a twofold higher mortality incidence, resulting in a disproportionately higher risk of death from TNBC, and WHEREAS, advances in breast cancer screening and treatment over the last few decades have reduced the overall breast cancer mortality rate, yet the disproportionate impact of TNBC on racial and ethnic minority communities raises considerations of the underlying determinants driving the disparities, and WHEREAS, it is necessary to promote TNBC education, to raise awareness about the disease-related disparities, and to tackle inequities within the health care delivery system, such as inadequate access to screening, diagnostic testing, and care, to improve early detection and survival, NOW, THEREFORE, Be It Resolved by the Senate of the State of Florida:

PageTriple-Negative 2Breast ofCancer 3Awareness CODING:Day and Month.

WordsThis strickenmeasure arewould deletions;proclaim March 3, 2022, as Triple-Negative Breast Cancer Awareness Day and the month of March 2022 as Triple-Negative Breast Cancer Awareness Month.Digest Key Fiscal Committee:

wordsNO  Bill underlinedTextWHEREAS, areBreast additions.cancer is among the most commonly diagnosed cancers and the second leading cause of cancer death among women in the United States;

FloridaandWHEREAS, SenateApproximately -281,550 2023women (NP)will SRbe 138diagnosed 26-00351-23with 2023138__breast Thatcancer March 2023 is recognized as “Triple-Negative Breast Cancer Awareness Month” and Marchnearly 3,43,600 2023,will isdie recognizedwith asthis “Triple-Negativemalignancy Breast Cancer Awareness Day” in Florida.2022;

PageandWHEREAS, 3Triple-negative breast cancer is one of 3many CODING:forms of breast cancer and accounts for about 15 to 30 percent of all diagnosed invasive breast cancer cases in the United States;

WordsandWHEREAS, strickenMore arethan deletions;53,700 new breast cancer cases in 2019 in the United States were triple-negative breast cancer with higher prevalence among younger women, Black and Hispanic women, women with type 2 diabetes or carrying excess weight in the abdomen area, and women with breast cancer gene 1 (BRCA1) mutations;

wordsandWHEREAS, underlinedDue areto additions.its aggressive behavior, triple-negative breast cancer grows quickly and is more likely to have spread at the time it is found and is more likely to come back after treatment than other types of breast cancer;

andWHEREAS, People diagnosed with metastatic triple-negative breast cancer have a less than 30 percent chance of surviving past five years;

and WHEREAS, Triple-negative breast cancer cells do not contain three key receptors that medicines typically target in other types of breast cancers.

As a result, there are limited treatment options that can be used to treat the cancer;

andWHEREAS, Patients with an early diagnosis of triple-negative breast cancer can often be treated with chemotherapy, radiation, and surgery.

However, the limited therapies available specifically addressing the management of triple-negative breast cancer has made treating this disease a challenge for clinicians;

andWHEREAS, Recent innovation in targeted therapies have fueled advances in the fight against triple-negative breast cancer;

andWHEREAS, Studies have shown that triple-negative breast cancer disease-specific mortality rates are often higher for patients who have Medicaid or Medicare or are from lower socioeconomic backgrounds.

Further, compared with non-Hispanic white women, Black women are 48 percent less likely to receive guideline-adherent care and have an approximate two-fold higher mortality incidence, resulting in a disproportionately higher risk of death from triple-negative breast cancer;

andWHEREAS, Advances in breast cancer screening and treatment over the last few decades have reduced the overall breast cancer mortality rate, yet the disproportionate impact of triple-negative breast cancer on racial and ethnic minority communities raises considerations about the underlying determinants driving the disparities;

andWHEREAS, It is necessary to promote triple-negative breast cancer education, raise awareness about the disease-related disparities, and tackle inequities within health care delivery, including inadequate access to screening, diagnostic testing, and care, in order to improve early detection and survival;

andWHEREAS, Additional legislative provisions should be examined to safeguard affordable, continuous, and equitable patient access to triple-negative breast-cancer-related care, services, and medicines along the entire continuum of care;

andWHEREAS, The Legislature supports health promotion initiatives that target underserved communities disproportionately impacted by triple-negative breast cancer and that promote cultural sensitivity and workforce diversity policies in health care provider training and guarantee timely patient access to clinically appropriate treatment options identified in the National Comprehensive Cancer Network (NCCN) Guidelines;

now, therefore, be itResolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature proclaims March 3, 2022, as Triple-Negative Breast Cancer Awareness Day and the month of March 2022 as Triple-Negative Breast Cancer Awareness Month;

and be it furtherResolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.